FDA Revises Emergency Use Authorization for Paxlovid
The FDA has announced a change regarding Paxlovid, stating that product manufactured and labeled in accordance with the Emergency Use Authorization is now only authorized for use through the expiration date or through March 8, 2024, whichever is earlier. NDA-labeled Paxlovid will, however, maintain emergency use authorization for the treatment of mild-to-moderate COVID-19 in some patients who are at high risk for progression to severe COVID-19.
SGLT2s and GLP-1s: Promising Alternative Treatments for Diabetics with Heart Disease
Some non-insulin medications are contraindicated in patients with certain cardiac conditions — a fact that can make caring for diabetic residents a challenge. Fortunately, two drug classes have shown to be effective alternatives for those with both diabetes and heart disease.
SinguLab Announces Integration with PointClickCare
PharMerica's partner SinguLab®, a nationwide provider of precision medicine and diagnostics solutions, recently announced its expanded integration with PointClickCare Technologies Inc., the leading cloud-based software platform for the senior care continuum. This integration will enable providers to identify potentially dangerous drug-gene interactions for their residents, allowing for the seamless delivery of pharmacogenomic risk assessments and more personalized care.
F756 provides guidance to surveyors regarding the Drug Regimen Review. In our latest Compliance Cue, learn about the requirements, what surveyors will look for, and how your facility can stay in compliance.
Policy Update: Proposed Overtime Rule & Potential Impact on the I/DD Sector
Last fall, the U.S. Department of Labor issued Defunding and Delimiting the Exemptions for Executive Administrative, Professional, Outside Sales, and Computer Employees (Overtime Rule), a notice of proposed rulemaking. An analysis by ANCOR revealed that the implementation of this rule would mean more than $1 billion in additional costs for Medicaid I/DD providers in the first year alone.
